Alabama State University partnered with ViiV Healthcare during its 2024 Homecoming to address HIV prevention and awareness.

ViiV Healthcare sponsored events to address the climbing rates of HIV infections on HBCU campuses and the surrounding Black ...

During homecoming festivities at Alabama State University, a unique pharmaceutical company was on campus to promote HIV ...

Compounding pharmacies sued the FDA after its declaration, bringing an end to the sale of the "copycat" drugs they provide. Meanwhile, as demand soars for weight loss drugs, WeightWatchers eyes ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

On the campus of Alabama State University, ViiV Healthcare transformed the annual celebration into a platform for HIV ...

ViiV Healthcare’s latest HIV prevention campaign coincided with one of the biggest weekends of the year at Alabama State University.

Lenacapavir, a bi-annual injectable treatment for HIV prevention (PrEP), is being celebrated as a major advancement in the ...

Dr. Lataillade brings over two decades of in-depth research experience to the CytoDyn team, with robust expertise investigating novel drug products and therapies. He most recently served as Vice ...

ViiV Healthcare has announced plans to triple its annual supply of long-acting cabotegravir for HIV pre-exposure prophylaxis ...

Note: ViiV’s announcement can be read on their site at ...

Responding to ViiV's announcement on long-acting cabotegravir , UNAIDS Executive Director Winnie Byanyima said:"New HIV ...